| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,922 |
9,312 |
$2.85M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,580 |
6,242 |
$889K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,039 |
8,333 |
$80K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
242 |
230 |
$45K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,295 |
1,194 |
$41K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
462 |
432 |
$36K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
102 |
90 |
$34K |
| 80053 |
Comprehensive metabolic panel |
2,910 |
2,668 |
$31K |
| 0240U |
|
152 |
141 |
$24K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
608 |
558 |
$19K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
242 |
211 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
242 |
227 |
$8K |
| 83690 |
|
882 |
810 |
$7K |
| 84703 |
|
747 |
685 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
97 |
95 |
$6K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
12 |
12 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
37 |
37 |
$4K |
| 81001 |
|
1,018 |
961 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
65 |
64 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
530 |
487 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
214 |
198 |
$2K |
| 87631 |
|
21 |
21 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
84 |
77 |
$2K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
14 |
13 |
$2K |
| 81003 |
|
417 |
383 |
$955.52 |
| 84484 |
|
46 |
42 |
$674.56 |
| 87430 |
|
44 |
41 |
$571.20 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14 |
12 |
$550.69 |
| 59025 |
Fetal non-stress test |
13 |
12 |
$529.70 |
| 71045 |
Radiologic examination, chest; single view |
13 |
12 |
$521.44 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
41 |
40 |
$341.70 |
| 87081 |
|
40 |
37 |
$258.48 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
15 |
13 |
$118.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
77 |
72 |
$53.75 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
52 |
48 |
$29.78 |